Pacira BioSciences Newsroom

RBC Capital Reiterates Sector Perform on Pacira BioSciences, Maintains $18 Price Target

Benzinga00:41

Pacira BioSciences Analyst Ratings

BenzingaJan 13 21:33

Truist Financial Maintains Pacira BioSciences(PCRX.US) With Sell Rating

Futu NewsJan 13 21:31

Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Raises Target Price to $30

Futu NewsJan 13 19:31

Needham Maintains Buy on Pacira BioSciences, Raises Price Target to $30

BenzingaJan 13 18:44

Raymond James Maintains Pacira BioSciences(PCRX.US) With Hold Rating

Futu NewsJan 11 09:32

RBC Raises Price Target on Pacira Biosciences to $18 From $16, Keeps Sector Perform Rating

MT NewswiresJan 7 20:51

H.C. Wainwright Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $39

Futu NewsDec 6, 2024 00:36

HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $39 Price Target

BenzingaDec 4, 2024 19:29

Pacira BioSciences Analyst Ratings

BenzingaDec 4, 2024 19:26

Pacira BioSciences Price Target Cut to $17.00/Share From $25.00 by Barclays

Dow JonesNov 12, 2024 23:13

Pacira BioSciences Is Maintained at Equal-Weight by Barclays

Dow JonesNov 12, 2024 23:13

Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $22

Futu NewsNov 8, 2024 04:31

Pacira BioSciences Analyst Ratings

BenzingaNov 8, 2024 01:32

RBC Capital Adjusts Price Target on Pacira Biosciences to $16 From $15, Maintains Sector Perform Rating

MT NewswiresNov 7, 2024 22:35

Truist Financial Maintains Pacira BioSciences(PCRX.US) With Sell Rating

Futu NewsNov 7, 2024 22:35

H.C. Wainwright Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $39

Futu NewsNov 7, 2024 19:31

Truist Financial Maintains Pacira BioSciences(PCRX.US) With Sell Rating

Futu NewsOct 22, 2024 19:31

RBC Capital Maintains Sector Perform on Pacira BioSciences, Raises Price Target to $15

BenzingaOct 4, 2024 23:55

Pacira BioSciences Analyst Ratings

BenzingaOct 4, 2024 23:54